[go: up one dir, main page]

CR20140358A - Sistema para la administración de fármacos - Google Patents

Sistema para la administración de fármacos

Info

Publication number
CR20140358A
CR20140358A CR20140358A CR20140358A CR20140358A CR 20140358 A CR20140358 A CR 20140358A CR 20140358 A CR20140358 A CR 20140358A CR 20140358 A CR20140358 A CR 20140358A CR 20140358 A CR20140358 A CR 20140358A
Authority
CR
Costa Rica
Prior art keywords
drug administration
administration system
drugs
administration
active substances
Prior art date
Application number
CR20140358A
Other languages
English (en)
Inventor
Heikki Lyytikäinen
Harri Jukarainen
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47666152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20140358(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of CR20140358A publication Critical patent/CR20140358A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Nanotechnology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Un sistema para la administración de fármacos para laliberación controlada de sustancias terapéuticamente activasa una tasa de liberación predeterminada, esencialmenteconstante durante un período de tiempo prolongado.
CR20140358A 2012-01-23 2014-07-23 Sistema para la administración de fármacos CR20140358A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20125069 2012-01-23
PCT/FI2013/050068 WO2013110856A1 (en) 2012-01-23 2013-01-22 A drug delivery system

Publications (1)

Publication Number Publication Date
CR20140358A true CR20140358A (es) 2014-11-17

Family

ID=47666152

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140358A CR20140358A (es) 2012-01-23 2014-07-23 Sistema para la administración de fármacos

Country Status (38)

Country Link
US (1) US10500381B2 (es)
EP (1) EP2806893B1 (es)
JP (1) JP6236401B2 (es)
KR (1) KR102004014B1 (es)
CN (1) CN104144702B (es)
AR (1) AR089765A1 (es)
AU (1) AU2013213514B2 (es)
BR (1) BR112014017834B1 (es)
CA (1) CA2861947A1 (es)
CL (1) CL2014001935A1 (es)
CO (1) CO7020911A2 (es)
CR (1) CR20140358A (es)
CU (1) CU24431B1 (es)
CY (1) CY1120773T1 (es)
DK (1) DK2806893T3 (es)
DO (1) DOP2014000171A (es)
EA (1) EA032208B1 (es)
EC (1) ECSP14010605A (es)
ES (1) ES2691635T3 (es)
HR (1) HRP20181707T1 (es)
IL (1) IL233599B (es)
LT (1) LT2806893T (es)
MX (1) MX355961B (es)
MY (1) MY172812A (es)
NZ (1) NZ627461A (es)
PE (1) PE20141818A1 (es)
PH (1) PH12014501654B1 (es)
PL (1) PL2806893T3 (es)
PT (1) PT2806893T (es)
RS (1) RS57911B1 (es)
SG (1) SG11201404032SA (es)
SI (1) SI2806893T1 (es)
TR (1) TR201815247T4 (es)
TW (1) TWI626951B (es)
UA (1) UA116197C2 (es)
UY (1) UY34583A (es)
WO (1) WO2013110856A1 (es)
ZA (1) ZA201406206B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
HRP20181794T1 (hr) * 2014-06-28 2018-12-28 Laboratorios Andrómaco S.A. Cervikalni pesar koji sadrži progesteron za produljeno, neprekidno i kontinuirano oslobađanje, koji se koristi za spriječavanje prijevremenog porođaja
HK1254072A1 (zh) * 2015-12-21 2019-07-12 Bayer Oy 制造阴道环的方法
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
MX2020007323A (es) 2017-09-27 2020-09-07 Bayer Oy Un metodo para modificar la liberacion de un agente terapeuticamente activo de una matriz elastomerica.
CN109954198B (zh) * 2017-12-25 2021-10-12 先健科技(深圳)有限公司 药物球囊及其制备方法
BR112021016369A2 (pt) * 2019-02-19 2021-10-19 Particle Sciences Inc. Dispositivo de distribuição, e, métodos para produzir o dispositivo de distribuição de fármaco e para distribuir um ou mais agentes farmacêuticos ativos

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
AU2001258442A1 (en) 2000-05-10 2001-11-20 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
DE10209979A1 (de) * 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
US7279457B2 (en) 2004-03-12 2007-10-09 Biodel, Inc. Rapid acting drug delivery compositions
ES2293193T5 (es) 2004-07-13 2012-06-13 Bayer Schering Pharma Oy Sistema de suministro retardado con descarga inicial controlada
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
WO2006085335A2 (en) 2005-01-03 2006-08-17 Lupin Limited Pharmaceutical composition of acid labile substances
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
US8137327B2 (en) 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
AU2007324588B2 (en) 2006-11-20 2012-09-13 Intervet International B.V. Helically-shaped drug delivery system
AR066166A1 (es) * 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI121000B (fi) 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
WO2012092283A1 (en) * 2010-12-27 2012-07-05 Dow Corning Corporation Drug delivery dispersion and film formed therefrom

Also Published As

Publication number Publication date
HK1203802A1 (en) 2015-11-06
CY1120773T1 (el) 2019-12-11
CO7020911A2 (es) 2014-08-11
RS57911B1 (sr) 2019-01-31
US20140350488A1 (en) 2014-11-27
ECSP14010605A (es) 2015-12-31
LT2806893T (lt) 2018-12-10
CU20140094A7 (es) 2014-11-27
UY34583A (es) 2013-09-02
SI2806893T1 (sl) 2019-02-28
ZA201406206B (en) 2019-06-26
DOP2014000171A (es) 2014-08-15
TW201343204A (zh) 2013-11-01
MY172812A (en) 2019-12-12
CN104144702A (zh) 2014-11-12
EA201400834A1 (ru) 2014-12-30
BR112014017834A2 (es) 2017-06-20
MX2014008906A (es) 2014-08-26
AU2013213514A1 (en) 2014-08-07
HRP20181707T1 (hr) 2019-02-22
JP6236401B2 (ja) 2017-11-22
KR102004014B1 (ko) 2019-07-25
CU24431B1 (es) 2019-07-04
TWI626951B (zh) 2018-06-21
EP2806893A1 (en) 2014-12-03
NZ627461A (en) 2016-07-29
BR112014017834A8 (pt) 2017-07-11
PE20141818A1 (es) 2014-12-18
US10500381B2 (en) 2019-12-10
TR201815247T4 (tr) 2018-11-21
DK2806893T3 (en) 2018-11-05
BR112014017834B1 (pt) 2021-05-18
AR089765A1 (es) 2014-09-17
ES2691635T3 (es) 2018-11-28
PH12014501654A1 (en) 2014-10-13
CL2014001935A1 (es) 2015-04-10
PT2806893T (pt) 2018-11-09
CA2861947A1 (en) 2013-08-01
PH12014501654B1 (en) 2014-10-13
IL233599B (en) 2019-07-31
WO2013110856A1 (en) 2013-08-01
UA116197C2 (uk) 2018-02-26
IL233599A0 (en) 2014-08-31
PL2806893T3 (pl) 2019-01-31
CN104144702B (zh) 2018-03-06
EA032208B1 (ru) 2019-04-30
MX355961B (es) 2018-05-07
AU2013213514B2 (en) 2017-07-13
JP2015504083A (ja) 2015-02-05
EP2806893B1 (en) 2018-07-18
KR20140127262A (ko) 2014-11-03
SG11201404032SA (en) 2014-08-28

Similar Documents

Publication Publication Date Title
CR20140358A (es) Sistema para la administración de fármacos
EP2683431A4 (en) DRUG DELIVERY SYSTEM
EP2991711A4 (en) DRUGS CHARGE DEVICE
MX2013006591A (es) Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
DK2925272T3 (da) Lægemiddelopbevarings-, udleverings- og administrationssystem
BR112013014616A2 (pt) sistema terapêutico transdérmico para a administração de uma substância ativa
BR112013029199A2 (pt) sistema de distribuição de fármacos, dispositivo de distribuição de dois fármacos, método para preparar o mesmo, comprimido para administração sublingual de um ingrediente ativo, e, método para a administração de um ingrediente ativo a um indivíduo
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
EP2919767A4 (en) SYSTEM FOR THE TRANSMUCOSAL ADMINISTRATION OF MEDICINAL PRODUCTS
PH12012502082A1 (en) Combination of active loaded granules with additional actives
EP2943235A4 (en) FLOW-OPERATED VALVE FOR IMPLANTABLE AGGREGATE FREEZING DEVICE
EP2968368A4 (en) CRANIAL DISTRIBUTION OF MEDICINAL PRODUCTS
EP2945686A4 (en) APPARATUS FOR DRUG DELIVERY IN THE TISSUE SYSTEM
EA201490862A1 (ru) Осмотически активная система вагинальной доставки
EP3661576A4 (en) MEDICAL NEBULIZER FOR FAST DRUG DELIVERY
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
EP2632902A4 (en) IMPROVED SYSTEM FOR ORAL ADMINISTRATION OF A MEDICAMENT
MX2016000103A (es) Dispositivo de administracion de farmaco oral y metodos de uso del mismo.
EP2667917A4 (en) DETACHABLE ACTIVE COMPOUND DEVICE
EP2939663A4 (en) MELT EXTRUDED PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE AND MEDICAMENT FOR ORAL ADMINISTRATION THEREWITH
EP2548594C0 (en) Pharmaceutical dosage forms of intrathecal baclofen and related delivery system
IN2013MU03370A (es)
EA201991359A1 (ru) Фармацевтические лекарственные формы
WO2016020936A3 (en) A novel oral gastroretentive pharmaceutical dosage form
EA201992463A1 (ru) Система доставки лекарственного средства